These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27093861)

  • 1. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
    Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
    Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
    Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
    Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
    Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.
    Plataniotis GA; Theofanopoulou MA; Sotiriadou K; Kyrgias G
    Breast Cancer; 2010; 17(1):42-7. PubMed ID: 19350358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.
    Chadha M; Woode R; Sillanpaa J; Lucido D; Boolbol SK; Kirstein L; Osborne MP; Feldman S; Harrison LB
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):40-4. PubMed ID: 23290443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
    Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
    Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
    Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.
    Zygogianni A; Kouloulias V; Antypas C; Armpilia C; Kyrgias G; Kouvaris J
    Breast J; 2014; 20(1):74-8. PubMed ID: 24237451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
    Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
    Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.